GeneReach Biotechnology Financials
| 4171 Stock | TWD 27.20 0.15 0.55% |
GeneReach |
Understanding current and past GeneReach Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GeneReach Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in GeneReach Biotechnology's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in GeneReach Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GeneReach Biotechnology. Check GeneReach Biotechnology's Beneish M Score to see the likelihood of GeneReach Biotechnology's management manipulating its earnings.
GeneReach Biotechnology Stock Summary
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. GeneReach Biotechnology Corp. was founded in 2004 and is headquartered in Taichung, Taiwan. GENEREACH BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0004171004 |
| Business Address | Central Science Park, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.genereach.com |
| Phone | 886 4 2463 9869 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in GeneReach Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of GeneReach Stock, because this is throwing your money away. Analyzing the key information contained in GeneReach Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
GeneReach Biotechnology Key Financial Ratios
There are many critical financial ratios that GeneReach Biotechnology's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that GeneReach Biotechnology reports annually and quarterly.GeneReach Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GeneReach Biotechnology's current stock value. Our valuation model uses many indicators to compare GeneReach Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GeneReach Biotechnology competition to find correlations between indicators driving GeneReach Biotechnology's intrinsic value. More Info.GeneReach Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for GeneReach Biotechnology is roughly 2.28 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GeneReach Biotechnology's earnings, one of the primary drivers of an investment's value.GeneReach Biotechnology Market Pulse
| Quote | 27.20 |
| Change(%) | 0.55 |
| Change | 0.15 |
| Open | 27.05 |
| Low | 27.0 |
| High | 27.65 |
| Volume | 0 |
| Exchange | TWO |
GeneReach Biotechnology Thematic Clasifications
GeneReach Biotechnology is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
GeneReach Biotechnology February 5, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of GeneReach Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GeneReach Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of GeneReach Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing GeneReach Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GeneReach Biotechnology's daily price indicators and compare them against related drivers.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 9.58 | |||
| Value At Risk | (3.40) | |||
| Potential Upside | 2.03 |
Additional Tools for GeneReach Stock Analysis
When running GeneReach Biotechnology's price analysis, check to measure GeneReach Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneReach Biotechnology is operating at the current time. Most of GeneReach Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneReach Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneReach Biotechnology's price. Additionally, you may evaluate how the addition of GeneReach Biotechnology to your portfolios can decrease your overall portfolio volatility.